Antitumor effect of interleukin-2 against renal cell carcinoma

Mototsugu Oya, K. Marumo, H. Tazaki

Research output: Contribution to journalArticle

Abstract

Renal cell carcinoma (RCC) is one of the most insensitive urologic tumors to either radiotherapy or anticancer chemotherapy. Several reports have shown that interferon (IFN) is the agent of great promise to treat advanced RCC. However, the effectiveness of IFN is limited.1) Eighteen patients with advanced RCC were treated by IL2. Antitumor effects were evaluated according to immunological parameters and survival rates.

Original languageEnglish
Pages (from-to)129-130
Number of pages2
JournalAnnals of Cancer Research and Therapy
Volume2
Issue number1
DOIs
Publication statusPublished - 1993

    Fingerprint

Keywords

  • Interleukin-2
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Cite this